[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019 [J]. CA Cancer J Clin, 2019, 69(1): 7-34. DOI: 10.3322/caac.21551.
[2] 姚卫红. 雌激素依赖型和非雌激素依赖型子宫内膜癌的病理特征[J]. 中国实用医刊,2018,45(10):54-57. DOI:10.3760/cma.j.issn.1674-4756.2018.10.017.
[3] Saleh M, Virarkar M, Bhosale P, et al. Endometrial cancer, the current international federation of gynecology and obstetrics staging system, and the role of imaging [J]. J Comput Assist Tomogr, 2020, 44(5): 714-729. DOI: 10.1097/RCT.0000000000001025.
[4] 邵洋,姚超,徐崧圆,等. 微小RNA-106通过调控PTEN/PI3K/AKT信号通路影响子宫内膜癌RL95-2细胞生物学行为的研究[J]. 实用临床医药杂志,2022,26(8):104-110. DOI:10.7619/jcmp.20214674.
[5] 王志敏,许振,石洪堂,等. 微卫星状态与p53在Ⅰ型子宫内膜癌中的表达及其相关性分析[J]. 现代妇产科进展,2020,29(10):766-769. DOI:10.13283/j.cnki.xdfckjz.2020. 10.009.
[6] 刘晓智,张春艳,张立东,等. 肝细胞癌组织SUMO化修饰成员表达变化及其临床意义[J]. 山东医药,2022,62(19):55-58. DOI:10.3969/j.issn.1002-266X.2022.19.013.
[7] Chen LC, Hsieh YL, Tan GYT, et al. Differential effects of SUMO1 and SUMO2 on circadian protein PER2 stability and function [J]. Sci Rep, 2021, 11(1):14431. DOI: 10.1038/s41598-021-93933-y.
[8] Kukkula A, Ojala VK, Mendez LM, et al. Therapeutic potential of targeting the SUMO pathway in cancer [J]. Cancers (Basel), 2021, 13(17):4402. DOI: 10.3390/cancers13174402.
[9] Bawa-Khalfe T, Yang FM, Ritho J, et al. SENP1 regulates PTEN stability to dictate prostate cancer development [J]. Oncotarget, 2017, 8(11): 17651-17664. DOI: 10.18632/oncotarget.13283.
[10] 黄河,王磊,巴音达拉,等.SENP1调控CCNE1参与结肠癌的增殖、侵袭和成瘤能力[J].山西医科大学学报, 2022, 53(3): 279-286. DOI: 10.13753/j.issn.1007-6611. 2022.03.004.
[11] Kunz K, Piller T, Müller S. SUMO-specific proteases and isopeptidases of the SENP family at a glance [J]. J Cell Sci, 2018, 131(6):jcs211904. DOI: 10.1242/jcs.211904.
[12] 柳卓,田雪飞,曾普华. 肝癌中蛋白质翻译后修饰的研究进展[J]. 中国药理学通报,2022,38(6):828-831. DOI:10.12360/CPB202107033.
[13] 邓思远,贺德. SUMO在恶性肿瘤中的表达及其分子机制[J]. 医学综述,2020,26(17):3434-3438,3443. DOI: 10.3969/j.issn.1006-2084.2020.17.020.
[14] Cui CP, Wong CC, Kai AK, et al. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop [J]. Gut, 2017, 66(12): 2149-2159. DOI: 10.1136/gutjnl-2016-313264.
[15] 聂禹菲,郭红燕,高妍,等. 子宫内膜癌分子分型与肥胖及代谢异常合并症的关系[J]. 实用妇产科杂志,2022,38(7):555-558.
[16] 王蒙蒙,张丽华. Pole基因在子宫内膜癌中的研究进展[J]. 诊断病理学杂志,2021,28(7):582-584. DOI:10.3969/j.issn.1007-8096.2021.07.017.
[17] 支文雪,刘红刚. 子宫内膜癌分子分型的研究进展[J]. 临床与实验病理学杂志,2021,37(3):321-323,326. DOI:10.13315/j.cnki.cjcep.2021.03.015.
[18] León-Castillo A, Gilvazquez E, Nout R, et al. Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas [J]. J Pathol, 2020, 250(3): 312-322. DOI: 10.1002/path.5373.
[19] 王嵘. SENP1的生理功能研究进展[J]. 军事医学,2015(10):805-807. DOI: 10.7644/j.issn.1674-9960.2015.10.018.
[20] Wang C, Tao W, Ni S, Chen Q. SENP1 interacts with HIF1α to regulate glycolysis of prostatic carcinoma cells [J]. Int J Biol Sci, 2019, 15(2):395-403. DOI: 10.7150/ijbs.27256.
|